EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY
EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY
批准号:
8233423
负责人:
SERGEI A GRANDO
金额:
$36.36万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2013-03-31
关键词:
AcetylcholineAntidotesApoptosisBindingBinding SitesBirthButanonesCell CycleCell physiologyCellsCessation of lifeCholinergic ReceptorsChronicDataDevelopmentDifferentiation and GrowthEnvironmental Tobacco SmokeEnzymesEpigenetic ProcessEpithelialEpithelial CellsEpitheliumEtiologyFeedbackFundingGastrointestinal tract structureGeneticGoalsHead and Neck CancerHormonesHumanIn VitroKnowledgeLeadLearningLigandsLigationMaintenanceMediatingMedicalMolecularMuscarinicsN&apos-nitrosonornicotineNicotineNicotinic AntagonistsNicotinic ReceptorsNitrosaminesOralOral PathologyPathogenesisPathway interactionsPharmacologyPhysiologicalPlayPrevention programProcessProteinsReceptor GeneRegulationResearchRiskRoleSignal PathwaySignal TransductionSmokeless TobaccoTestingTobaccoToxic effectTumor PromotersUrokinase Plasminogen Activator ReceptorWorkaddictionautocrinecell growthcholinergicin vivokeratinocytemalignant mouth neoplasmnoveloral biologyparacrinepreventprotective effectreceptor-mediated signalingresponsesmoking cessationtooltumorigenesistumorigenic
中文摘要
我们需要资金来支持我们正在进行的识别分子机制的研究。
乙酰胆碱及其药理类似物和烟草制品对口腔角质形成细胞的影响。
角质形成细胞出生和死亡的连续周期是一个自我维持的过程,部分受局部控制。
荷尔蒙通过信号通路偶联每种类型的ACh受体来调节
特殊的细胞功能。游离细胞递质ACh以与生理相关的浓度存在于
上消化道的衬里上皮。OKC表达ACh合成酶和降解酶,
以及烟碱型和毒鼠型ACh受体。一种通过烟碱调节细胞的新范式
ACh受体(NAChRs)是在对胆碱能蛋白的研究中发现的,这种蛋白被称为surp(分泌型)
哺乳动物Ly-6/尿激酶型纤溶酶原激活物受体相关蛋白)-1和-2。初步结果
提示slurp-1和slurp-2对角质形成细胞的增殖、凋亡和分化具有调节作用。多数
重要的是,口香糖和专业的尼古丁拮抗剂可以部分地消除尼古丁衍生的能力。
亚硝胺4-(methylnitrosamino)-1-(3¿pyridyl)-1-butanone和N‘-亚硝基烟碱
以引起不朽的OKC的转变。我们将测试以下工作假设:1)
NNK的病理生物学效应主要是通过α7和/或α9 nAChR(S)介导的,而NNN则主要通过α3制造的nAChR(S)介导;2)唾液蛋白可以防止口腔细胞亚硝胺依赖的转化
体内和体外,并取消烟草/尼古丁依赖的角质形成细胞周期、生长和
3)SLULP-1主要与NNK竞争结合同源五聚体nAChR(S)和
Surp-2与NNN在异五聚体nAChR(S)的结合位点上,这两个Surp都干扰
亚硝胺诱导nAChR信号转导。具体目标是确定:1)角质形成细胞的作用
NAChRs在介导烟草亚硝胺的病理生物学效应中的作用;2)slurp-1和-2在
OKC对烟草毒性的生理保护;3)受体介导的信号机制
调节Surp-1和-2对OKC的作用。
英文摘要
Funding is requested to support our ongoing studies toward identification of molecular mechanisms mediating
effects of acetylcholine (ACh), its pharmacologic congeners and tobacco products on oral keratinocytes (OKC).
The continuous cycle of keratinocyte birth and death is a self-sustained process controlled, in part, by the local
hormone ACh through the signaling pathways that couple each type of ACh receptors to regulation of a
particular cell function. Free cytotransmitter ACh is present in physiologically-relevant concentrations in the
epithelium lining the upper digestive tract. OKC express both the ACh synthesizing and degrading enzymes,
and both nicotinic and muscarinic classes of ACh receptors. A novel paradigm of cell regulation via nicotinic
ACh receptors (nAChRs) has been discovered in studies of the cholinergic proteins termed SLURP (secreted
mammalian Ly-6/urokinase plasminogen activator receptor-related protein)-1 and -2. Preliminary results
indicate that SLURP-1 and -2 regulate keratinocyte proliferation, apoptosis and differentiation. Most
importantly, SLURPs and professional nicotinic antagonists can abolish, in part, the abilities of the nicotinederived
nitrosamines 4-(methylnitrosamino)-1-(3¿pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN)
to cause transformation of immortalized OKC. We will test the following working hypotheses: 1) the
pathobiologic effect of NNK is mediated predominantly via alpha7 and/or alpha9 nAChR(s), and that of NNN¿via alpha3-made nAChR(s); 2) SLURP proteins can prevent nitrosamine-dependent transformation of oral cells both in
vivo and in vitro, and abolish tobacco/nicotine-dependent alterations in the keratinocyte cell cycle, growth and
differentiation; and 3) SLURP-1 competes mainly with NNK for binding to the homopentameric nAChR(s) and
SLURP-2¿with NNN at the binding site of heteropentameric nAChR(s), and both SLURPs interfere with the
nitrosamine-induced nAChR signaling. The Specific Aims will be to determine: 1) the role of keratinocyte
nAChRs in mediating the pathobiologic effects of tobacco nitrosamines; 2) the roles for SLURP-1 and -2 in the
physiologic protection of OKC from tobacco toxicity; and 3) the receptor-mediated signaling mechanisms
mediating SLURP-1 and -2 actions on OKC.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1083/jcb.200206096
发表时间:
2002-10-28
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Arredondo J, Nguyen VT, Chernyavsky AI, Bercovich D, Orr-Urtreger A, Kummer W, Lips K, Vetter DE, Grando SA]
通讯作者:
Grando SA
DOI:
10.1016/j.lfs.2011.12.023
发表时间:
2012-11-27
期刊:
LIFE SCIENCES
影响因子:
6.1
作者:
[Chikova, Anna, Bernard, Hans-Ulrich, Shchepotin, Igor B., Grando, Sergei A.]
通讯作者:
Grando, Sergei A.
DOI:
10.1016/j.lfs.2012.03.041
发表时间:
2012-11-27
期刊:
LIFE SCIENCES
影响因子:
6.1
作者:
[Galitovskiy, Valentin, Chernyavsky, Alexander I., Edwards, Robert A., Grando, Sergei A.]
通讯作者:
Grando, Sergei A.
DOI:
10.1016/j.lfs.2012.02.004
发表时间:
2012-11-27
期刊:
LIFE SCIENCES
影响因子:
6.1
作者:
[Kalantari-Dehaghi, Mina, Bernard, Hans-Ulrich, Grando, Sergei A.]
通讯作者:
Grando, Sergei A.
DOI:
10.2147/jep.s7055
发表时间:
2009
期刊:
Journal of experimental pharmacology
影响因子:
--
作者:
[Arredondo J, Omelchenko D, Chernyavsky AI, Qian J, Skok M, Grando SA]
通讯作者:
Grando SA
共 6 条
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
-
批准号:8065942
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2010
-
负责人:SERGEI A GRANDO
-
依托单位:
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
-
批准号:7880444
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2010
-
负责人:SERGEI A GRANDO
-
依托单位:
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
-
批准号:8228055
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2010
-
负责人:SERGEI A GRANDO
-
依托单位:
Nicotinic Receptor Ligands and Tobacco-induced Lung Cancer
-
批准号:8417010
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2010
-
负责人:SERGEI A GRANDO
-
依托单位:
Pemphigus & Pemphigoid: from the bench to the bedside
-
批准号:7996440
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2010
-
负责人:SERGEI A GRANDO
-
依托单位:
Nicotinic receptor-mediated action of tobacco nitrosamines on respiratory cells
-
批准号:7145522
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2006
-
负责人:SERGEI A GRANDO
-
依托单位:
Nicotinic receptor-mediated action of tobacco nitrosamines on respiratory cells
-
批准号:7540594
-
项目类别:
-
资助金额:$14.76万
-
财政年份:2006
-
负责人:SERGEI A GRANDO
-
依托单位:
Can nicotinic antagonists prevent tobacco smoke-induced*
-
批准号:7001068
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2005
-
负责人:SERGEI A GRANDO
-
依托单位:
Can nicotinic antagonists prevent tobacco smoke-induced*
-
批准号:7091527
-
项目类别:
-
资助金额:$5.6万
-
财政年份:2005
-
负责人:SERGEI A GRANDO
-
依托单位:
Can nicotinic antagonists prevent tobacco smoke-induced*
-
批准号:7522178
-
项目类别:
-
资助金额:$1.81万
-
财政年份:2005
-
负责人:SERGEI A GRANDO
-
依托单位:
Epithelial Acetylcholine Oral Biology and Pathology
-
批准号:7514038
-
项目类别:
-
资助金额:$10.06万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
Epithelial Acetylcholine Oral Biology and Pathology
-
批准号:6708005
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
Regulation of Keratinocyte Migration by Acetylcholine
-
批准号:6752829
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY
-
批准号:7772334
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
Regulation of Keratinocyte Migration by Acetylcholine
-
批准号:6637903
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
Epithelial Acetylcholine Oral Biology and Pathology
-
批准号:6849734
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
Regulation of Keratinocyte Migration by Acetylcholine
-
批准号:7032221
-
项目类别:
-
资助金额:$8.21万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY
-
批准号:7367016
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY
-
批准号:7568208
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
Regulation of Keratinocyte Migration by Acetylcholine
-
批准号:7337302
-
项目类别:
-
资助金额:$27.02万
-
财政年份:2002
-
负责人:SERGEI A GRANDO
-
依托单位:
海外基金